Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis

他のバージョン（2件）を表示する

Background: Evaluating the long term benefit of therapy in multiple sclerosis (MS) is challenging. Although randomised controlled trials (RCTs) demonstrate therapeutic benefits on short term outcomes, the relationship between these outcomes and late disability is not established. Methods: In a patie...

書誌詳細
主要な著者:	Goodin, D, Traboulsee, A, Knappertz, V, Reder, A, Li, D, Langdon, D, Wolf, C, Beckmann, K, Konieczny, A, Ebers, G
フォーマット:	Journal article
出版事項:	2012

類似資料

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
著者:: Goodin, D, 等
出版事項: (2012)

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
著者:: Goodin, D, 等
出版事項: (2012)

Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.
著者:: Goodin, D, 等
出版事項: (2012)

Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study
著者:: Goodin, D, 等
出版事項: (2012)

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
著者:: Ebers, G, 等
出版事項: (2009)

Mortality in patients with multiple sclerosis.
著者:: Scalfari, A, 等
出版事項: (2013)

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial.
著者:: Ebers, G, 等
出版事項: (2010)

CAUSE OF DEATH IN MULTIPLE SCLEROSIS PATIENTS FROM THE 21-YEAR LONG-TERM FOLLOW-UP STUDY
著者:: Ebers, G, 等
出版事項: (2011)

The final results of the interferon beta-1b 16-year long-term follow-up study
著者:: Ebers, G, 等
出版事項: (2006)

The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes
著者:: Reder, A, 等
出版事項: (2008)

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
著者:: Reder, A, 等
出版事項: (2010)

EDSS and MRI burden of disease predict cognitive status at 16 years: data from the long term follow-up study
著者:: Langdon, D, 等
出版事項: (2007)

Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS.
著者:: Douglas S Goodin, 等
出版事項: (2011-01-01)

16-year long-term follow-up of interferon beta-1b treatment in patients with multiple sclerosis
著者:: Ebers, G, 等
出版事項: (2005)

Long-term follow up of interferon-beta-1b pivotal trial RRMS patients: design issues of a 16-year follow-up study
著者:: Ebers, G, 等
出版事項: (2004)

Causes of death among commercially insured multiple sclerosis patients in the United States.
著者:: Douglas S Goodin, 等
出版事項: (2014-01-01)

Treatment of multiple sclerosis with interferon beta-1b - Reply
著者:: Sibley, W, 等
出版事項: (1997)

INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY
著者:: Sibley, W, 等
出版事項: (1994)

Interferons in relapsing remitting multiple sclerosis.
著者:: Goodin, D
出版事項: (2003)

Cause of death in MS: Longterm follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study (BMJ Open (2012) 2 (e001972))
著者:: Goodin, D, 等
出版事項: (2013)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.
著者:: Petkau, A, 等
出版事項: (2004)

A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
著者:: Colin J. Ross, 等
出版事項: (2017-05-01)

Systemic interferon alfa in multiple sclerosis.
著者:: Weinshenker, BG, 等
出版事項: (1989)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
著者:: Ebers, G, 等
出版事項: (1997)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
著者:: Filippini, G, 等
出版事項: (2003)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
著者:: Filippini, G, 等
出版事項: (2003)

Age and disability accumulation in multiple sclerosis.
著者:: Scalfari, A, 等
出版事項: (2011)

Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis
著者:: Paul I. Creeke, 等
出版事項: (2013-01-01)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
著者:: Ebers, G, 等
出版事項: (1998)

Interferons in relapsing remitting multiple sclerosis: a systematic review.
著者:: Filippini, G, 等
出版事項: (2003)

Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection
著者:: Xuan Feng, 等
出版事項: (2019-11-01)

The evolution of interferon therapy in multiple sclerosis
著者:: O. V. Boyko, 等
出版事項: (2023-08-01)

Drug induced liver injury secondary to interferon-beta (IFN-β) in multiple sclerosis
著者:: V. Byrnes, 等
出版事項: (2006-01-01)

Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy
著者:: A. D. Kukushkina, 等
出版事項: (2024-08-01)

Association of smoking with risk of multiple sclerosis: a population-based study.
著者:: Ramagopalan, S, 等
出版事項: (2013)

Association of smoking with risk of multiple sclerosis: A population-based study
著者:: Ramagopalan, S, 等
出版事項: (2013)

Adherence to interferon β treatment in Kosovan multiple sclerosis registry
著者:: Blerim Myftiu, 等
出版事項: (2024-01-01)

EХPERIENCE IN INTERFERON β-1A USE FOR TREATMENT OF MULTIPLE SCLEROSIS IN CHILDREN
著者:: L. M. Kuzenkova, 等
出版事項: (2013-09-01)

Interferon beta treatment of multiple sclerosis.
著者:: Markovitz, D
出版事項: (1994)

CLINICALLY ISOLATED SYNDROME IN CHILDREN AND ADOLESCENTS — RISK FACTORS FOR MULTIPLE SCLEROSIS AND PROSPECTS OF USING INTRAMUSCULAR INTERFERON β-1A
著者:: O.V. Bykova, 等
出版事項: (2010-05-01)